A number of dysregulated miRNAs in myasthenia gravis patients, namely miR-21-5p, let-7a, and let 7f, have been shown to have ESR1-binding sites [102] implying the role of ER signaling in this autoimmune disorder. The gene discussed is ESR1; the disease is myasthenia gravis.